Product Program year 2020 Source: CMS Open Payments

Andexxa

Drug Hematology

NDC 69853-0101-1

Open in the dashboard

General payments

$264

14 payments

Research payments

$0

0 payments

Through program year 2020, $264 in general payments and $0 in research payments were reported against Andexxa (Hematology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2020 General $264 14

Breakdown

Who paid General payments · program year 2020
  1. Alexion Pharmaceuticals, Inc. $264 14 payments
Top recipients General payments · program year 2020
  1. Brian Perry Emergency Medicine · Dallas, TX $38 14% · 1 payment
  2. Kevin Cahill Surgical Critical Care · Camden, NJ $38 14% · 1 payment
  3. Namir Khandker Neurocritical Care · New Orleans, LA $24 9% · 1 payment
  4. David Holstein Neurology · Anaheim, CA $20 8% · 1 payment
  5. John Tsai Surgery · Brunswick, GA $19 7% · 1 payment

The top 5 of 14 recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Surgical Critical Care Surgery $75 28% · 3 practitioners
  2. Surgery $38 14% · 2 practitioners
  3. Emergency Medicine $38 14% · 1 practitioner
  4. Neurology Psychiatry & Neurology $29 11% · 2 practitioners
  5. Hematology & Oncology Internal Medicine $24 9% · 2 practitioners

The top 5 of 9 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. Georgia $68 26% · 4 recipients
  2. Delaware $38 14% · 1 recipient
  3. New Jersey $38 14% · 1 recipient
  4. California $33 12% · 2 recipients
  5. Louisiana $24 9% · 1 recipient

The top 5 of 9 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

14 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record